CD95 (Fas)-induced caspase-mediated proteolysis of NF-κB

Research output: Contribution to journalArticle

Abstract

Activation of the nuclear factor (NF)-κB transcription factor is instrumental for the immune response and the survival of peripheral activated T cells. We demonstrate that ligation of CD95 (Fas/APO1), a potent apoptotic stimulus in lymphocytes, results in repression of NF-κB activity in Jurkat T cells by inducing the proteolytic cleavage of NF-κB p65 (RelA) and p50. Inhibition of caspase-3-related proteases by a specific acetylated aldehyde (Ac-DEVD-CHO) prevented CD95-induced cleavage of p65 (RelA) or p50 and restored the inducibility of NF-κB in cells treated with an antibody against CD95. The addition of recombinant caspase-3 also resulted in proteolytic cleavage of RelA p65 and p50 in vitro. TNF-α treatment, unlike CD95 ligation, did not result in the death of Jurkat cells but did so in the presence of IκBαM, a transdominant inhibitor of NF-κB. These results suggest that intact, functional NF-κB maintains the survival of activated T cells, and that CD95-induced cleavage of NF-κB subunits sensitizes T cells to apoptosis and, hence, facilitates the decay of an immune response.

Original languageEnglish (US)
Pages (from-to)882-886
Number of pages5
JournalCancer Research
Volume58
Issue number5
StatePublished - Mar 1 1998

Fingerprint

Caspases
Proteolysis
T-Lymphocytes
Jurkat Cells
Caspase 3
Ligation
Aldehydes
Peptide Hydrolases
Transcription Factors
Lymphocytes
Apoptosis
Antibodies

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

CD95 (Fas)-induced caspase-mediated proteolysis of NF-κB. / Ravi, Rajani; Bedi, Asheesh; Fuchs, Ephraim J; Bedi, Atul.

In: Cancer Research, Vol. 58, No. 5, 01.03.1998, p. 882-886.

Research output: Contribution to journalArticle

@article{a567733e533a4a2cabe40c1d90f3ab7b,
title = "CD95 (Fas)-induced caspase-mediated proteolysis of NF-κB",
abstract = "Activation of the nuclear factor (NF)-κB transcription factor is instrumental for the immune response and the survival of peripheral activated T cells. We demonstrate that ligation of CD95 (Fas/APO1), a potent apoptotic stimulus in lymphocytes, results in repression of NF-κB activity in Jurkat T cells by inducing the proteolytic cleavage of NF-κB p65 (RelA) and p50. Inhibition of caspase-3-related proteases by a specific acetylated aldehyde (Ac-DEVD-CHO) prevented CD95-induced cleavage of p65 (RelA) or p50 and restored the inducibility of NF-κB in cells treated with an antibody against CD95. The addition of recombinant caspase-3 also resulted in proteolytic cleavage of RelA p65 and p50 in vitro. TNF-α treatment, unlike CD95 ligation, did not result in the death of Jurkat cells but did so in the presence of IκBαM, a transdominant inhibitor of NF-κB. These results suggest that intact, functional NF-κB maintains the survival of activated T cells, and that CD95-induced cleavage of NF-κB subunits sensitizes T cells to apoptosis and, hence, facilitates the decay of an immune response.",
author = "Rajani Ravi and Asheesh Bedi and Fuchs, {Ephraim J} and Atul Bedi",
year = "1998",
month = "3",
day = "1",
language = "English (US)",
volume = "58",
pages = "882--886",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - CD95 (Fas)-induced caspase-mediated proteolysis of NF-κB

AU - Ravi, Rajani

AU - Bedi, Asheesh

AU - Fuchs, Ephraim J

AU - Bedi, Atul

PY - 1998/3/1

Y1 - 1998/3/1

N2 - Activation of the nuclear factor (NF)-κB transcription factor is instrumental for the immune response and the survival of peripheral activated T cells. We demonstrate that ligation of CD95 (Fas/APO1), a potent apoptotic stimulus in lymphocytes, results in repression of NF-κB activity in Jurkat T cells by inducing the proteolytic cleavage of NF-κB p65 (RelA) and p50. Inhibition of caspase-3-related proteases by a specific acetylated aldehyde (Ac-DEVD-CHO) prevented CD95-induced cleavage of p65 (RelA) or p50 and restored the inducibility of NF-κB in cells treated with an antibody against CD95. The addition of recombinant caspase-3 also resulted in proteolytic cleavage of RelA p65 and p50 in vitro. TNF-α treatment, unlike CD95 ligation, did not result in the death of Jurkat cells but did so in the presence of IκBαM, a transdominant inhibitor of NF-κB. These results suggest that intact, functional NF-κB maintains the survival of activated T cells, and that CD95-induced cleavage of NF-κB subunits sensitizes T cells to apoptosis and, hence, facilitates the decay of an immune response.

AB - Activation of the nuclear factor (NF)-κB transcription factor is instrumental for the immune response and the survival of peripheral activated T cells. We demonstrate that ligation of CD95 (Fas/APO1), a potent apoptotic stimulus in lymphocytes, results in repression of NF-κB activity in Jurkat T cells by inducing the proteolytic cleavage of NF-κB p65 (RelA) and p50. Inhibition of caspase-3-related proteases by a specific acetylated aldehyde (Ac-DEVD-CHO) prevented CD95-induced cleavage of p65 (RelA) or p50 and restored the inducibility of NF-κB in cells treated with an antibody against CD95. The addition of recombinant caspase-3 also resulted in proteolytic cleavage of RelA p65 and p50 in vitro. TNF-α treatment, unlike CD95 ligation, did not result in the death of Jurkat cells but did so in the presence of IκBαM, a transdominant inhibitor of NF-κB. These results suggest that intact, functional NF-κB maintains the survival of activated T cells, and that CD95-induced cleavage of NF-κB subunits sensitizes T cells to apoptosis and, hence, facilitates the decay of an immune response.

UR - http://www.scopus.com/inward/record.url?scp=0032032627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032032627&partnerID=8YFLogxK

M3 - Article

C2 - 9500443

AN - SCOPUS:0032032627

VL - 58

SP - 882

EP - 886

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 5

ER -